Processed Electroencephalography-guided General Anesthesia and Outcomes in Major Abdominal Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorAssiut University

About this trial

This study aims to evaluate whether the reduction in the amount of intraoperative norepinephrine required to prevent hypotension, facilitated by processed electroencephalography (pEEG) -guided general anesthesia, will lead to a decrease in postoperative complications, particularly acute kidney injury (AKI).

Eligibility criteria

Qualifiers

Patients scheduled for major abdominal surgery lasting more than 2 hours under general anesthesia.

American Society of Anesthesiologists Physical Status (ASA) score I-III.

Age range of 18-70 years.

Both male and female patients.

Disqualifiers

Emergency surgeries.

Uncontrolled hypertension (systolic blood pressure >150 mm Hg) despite medication.

Recent acute cardiovascular events, including heart failure or acute coronary syndrome.

Chronic kidney disease with a glomerular filtration rate <30 ml/min/1.73 m² or requiring renal replacement therapy.

Trial design

Treatments tested in this trial

  • Processed electroencephalography (pEEG) Guided General Anesthesia
  • Non-pEEG-Guided General Anesthesia (with blinded pEEG monitoring)

Treatment groups

162 Participants
are divided into 2 treatment groups

Sponsors and collaborators